Well, it looks like Diabetes Insipidus is on the way out, at least from the naming point of view. After the work done in Basel (Universitätsspital Basel), recently published in The Lancet, an international consensus group proposed a name change from Diabetes Insipidus to Arginine Vasopressin Deficiency or AVP-D, or Arginine Vasopressin Resistance or AVP-R, depending on the type.
Last year, Got Diabetes Insipidus group director Pat Gildroy was asked to be the patient representative for the development and distribution of the DImond Patient Survey. Pat reached out to PWN for help in generating responses
Today’s podcast focuses on an opportunity to learn about a group of rare diseases that share a common condition with pituitary disease. Histiocytosis or histiocytic disorders are a group of rare diseases that occur when there is an overproduction of white blood cells known as histiocytes that can lead to organ damage and tumor formation. DI impacts almost 50% of Histiocytosis patients and 35% of pituitary patients.
Dr. Lewis Blevins discusses the normal ranges of endocrine lab tests and shares examples from his pituitary practice. Also, our guest this week, Pat Gildroy, who manages the Diabetes Insipidus Facebook group, Got DI, joins us for a fascinating discussion about this condition.
Help us increase the medical field’s knowledge of CDI by participating in this short five-minute anonymous survey. An international team of researchers will collect the patient data to help physicians and patients understand how to manage DI
From Lewis S. Blevins, Jr. MD – Vasopressin acts on the kidney to reabsorb water from the urine to restore plasma osmolarity to normal to prevent dehydration. Simple enough. Right? Hold on a minute! Our
From Lewis S. Blevins, Jr. MD – Ever wondered why your sense of thirst and the control of your diabetes insipidus reflected by the degree of polyuria might seem disconnected? Well, it’s because they are!
From Lewis S Blevins, Jr MD – One hundred ninety-eight persons completed our survey on diabetes insipidus. Approximately two-thirds of respondents reside in the United States whereas 14% live in Great Britain, 7% live in
This is a questionnaire/survey on Diabetes Insipidus. Thank you for participating. Your responses and insights will be gleaned to write an article for Pituitary World News. Click here to start the Diabetes Insipidus Survey And stay tuned
From Lewis S Blevins Jr., MD – desamino d-arginine vasopressin…..in case you ever wondered. DDAVP therapy has evolved somewhat over the past quarter of a century. When I started my training one of the common